Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Healthcare payment software maker Waystar outperformed analysts’ estimates in the second quarter, with executives touting broader deployments of its artificial intelligence investments and ongoing | The healthcare payment software maker brought in $319.7 million in second-quarter revenue, up 18% YOY.
Waystar beat Q2 with $319.7M revenue (+18% YoY), driven by AI-powered RCM deployments and $1M+ ACV bookings. Its $100B autonomous revenue cycle opportunity signals strong provider ROI in AI denial recovery—a critical healthcare IT budget priority.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise

Alignment Healthcare delivered a strong second quarter, in what CEO John Kao said was supported by the deployment of its new…

Venture capital funding for digital health startups is on an upswing, fueled by an AI-powered rebound following a post-pandemic…

Healthcare staffing shortages are a near-universal problem for healthcare providers. | The company currently works with more than…

Nine months after announcing its seed funding round, Prosper AI banked $30 million to scale its agentic AI platform to power…

Waystar Earns Overall "A" Rating from KLAS for Revenue Cycle Suites, Cementing Its Platform Advantage in a Fragmented Market

The number of health services deals dipped in the first half of 2026 but deal value "remained resilient" as strategic acquirers…